Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vistabex and Juvederm in Hemifacial Paralysis
NCT05012566Phase 2Unknown
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in facial paralysis, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
facial paralysis
Beyond the preview
Go deeper on NCT05012566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05012566.